Glaukos (GKOS) Change in Receivables (2014 - 2026)
Glaukos' (GKOS) quarterly Change in Receivables came in at $12.5 million in Q1 2026, up 1.16% year-on-year from $12.3 million in Q1 2025, and up 21.62% on a QoQ basis from $10.2 million in Q4 2025.
Glaukos (GKOS) Change in Receivables (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Change in Receivables data on file, last reported at $12.5 million in Q1 2026.
- On a quarterly basis, Change in Receivables rose 1.16% year-over-year to $12.5 million in Q1 2026; TTM through Mar 2026 was $53.2 million, a 97.85% increase from a year earlier, with the FY2025 full-year figure at $53.0 million, up 142.38% from the prior year.
- Change in Receivables for Q1 2026 stood at $12.5 million, up from $10.2 million in the prior quarter.
- Over the last five years, Change in Receivables for GKOS reached as high as $18.8 million in Q3 2025 and fell as low as -$175000.0 in Q3 2022.
- Historically, Change in Receivables has averaged $5.5 million across 5 years, with a median of $4.5 million in 2024.
- Across the five-year window, Change in Receivables slipped 22.64% in 2023 and soared 3784.17% in 2024, its largest moves.
- Year by year, Change in Receivables stood at $17000.0 in 2022, then surged by 717.65% to $139000.0 in 2023, then surged by 3784.17% to $5.4 million in 2024, then surged by 89.74% to $10.2 million in 2025, then gained by 21.62% to $12.5 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $12.5 million in Q1 2026, $10.2 million in Q4 2025, and $18.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | 12.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.46 Mn |
| Mar 31, 2026 | 12.46 Mn |
| Dec 31, 2025 | 10.24 Mn |
| Dec 31, 2025 | 10.24 Mn |
| Sep 30, 2025 | 18.79 Mn |
| Sep 30, 2025 | 18.79 Mn |
| Jun 30, 2025 | 11.67 Mn |
| Jun 30, 2025 | 11.67 Mn |
| Mar 31, 2025 | 12.32 Mn |
| Mar 31, 2025 | 12.32 Mn |
| Dec 31, 2024 | 5.40 Mn |
| Dec 31, 2024 | 5.40 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | 4.66 Mn |
| Jun 30, 2024 | 4.66 Mn |
| Mar 31, 2024 | 7.32 Mn |
| Mar 31, 2024 | 7.32 Mn |
| Dec 31, 2023 | 139,000.00 |
| Dec 31, 2023 | 139,000.00 |